BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 29, 2014
View Archived Issues
Lilly to initiate clinical study of cancer candidate LY-3164530
Read More
Asterias Biotherapeutics receives FDA clearance to begin phase I/IIa trial of AST-OPC1
Read More
Genentech acquires Seragon Pharmaceuticals and gains selective estrogen receptor degraders
Read More
Oprozomib receives FDA orphan drug designation for Waldenstrom's macroglobulinemia
Read More
FDA grants orphan drug designation to recombinant human pentraxin-2
Read More
Identification of a lncRNA biomarker for colorectal cancer prognosis
Read More
Generation of novel minimal saponin immunoadjuvant with improved profile
Read More
Robust non-human primate model of MERS-CoV
Read More
Host cell CDK9 prevents the replication of DNA viruses
Read More
Fujifilm begins phase I trial of FF-10501 in relapsed or refractory myelodysplastic syndromes
Read More
Isis begins phase III study of ISIS-APOCIII Rx in familial chylomicronemia syndrome
Read More
Discovery of novel antibacterial agents with improved in vivo clearance
Read More
Allergan divulges new S1P1 receptor agonists
Read More
Biotie regains global rights to tozadenant
Read More
Immunotech Laboratories completes early clinical testing of antiviral immunomodulator ITV-1
Read More
Scientists in China disclose novel xanthine oxidase inhibitors
Read More
Merck & Co. describes new NS5B inhibitors for HCV infection
Read More
FDA grants fast track status to Pfizer's Clostridium difficile vaccine
Read More
Amgen submits evolocumab BLA, reports Japanese phase III results
Read More
Cavion formed from merger of Tau Therapeutics and Xdynia
Read More
OncoPep completes financing round to support development of MM vaccine
Read More
Dezima reports findings from phase IIb study of TA-8995 for dyslipidemia
Read More
AstraZeneca's MEDI-4736 to be studied in immunological subsets of advanced colorectal cancer
Read More
Nuplazid selected as trade name for pimavanserin
Read More